Prognostic implications of signet ring cell histology in esophageal adenocarcinoma: A SEER database analysis

2013 ◽  
Vol 31 (15_suppl) ◽  
pp. 4067-4067
Author(s):  
Saikrishna S. Yendamuri ◽  
Miriam Huang ◽  
Usha Malhotra ◽  
Graham Walter Warren ◽  
Paul Bogner ◽  
...  

4067 Background: Signet ring cell esophageal adenocarcinoma histology has been difficult to study in a single institution series because of its relative rarity, yet has an anecdotal reputation for poor prognosis. We examined the Surveillance Epidemiology and End Results (SEER) database to assess the prognostic implications of this esophageal adenocarcinoma subtype. Methods: All patients with esophageal adenocarcinoma in the SEER database from 2004 – 2009 were included. Characteristics of patients with signet ring cell histology were compared to those without it. Univariate and multivariate analyses examining the relationship of signet ring cell histology with overall survival (censored at 72 months) were performed in all patients, as well as those undergoing surgical resection. Results: 597 of 11,838 (5%) study patients had signet ring cell histology. Patients with signet ring cell histology were similar in age, race, and gender distribution, but had a higher grade (p<0.001) and higher stage (p<0.001) at diagnosis. In both all-comers as well as those undergoing surgical resection, univariate analyses showed a worse survival in patients with signet ring cell esophageal cancer (HR = 1.24; 95% CI 1.13-1.37 and HR = 1.57; 95% CI 1.29-1.92 respectively). In multivariate analyses adjusting for age, gender, grade, stage, and race, patients with signet ring cell cancer had a worse prognosis than those with non-signet ring cell adenocarcinoma (HR = 1.20; 95% CI 1.09 -1.33). In surgically resected patients, this remained a trend, but did not reach statistical significance (HR = 1.16; 95% CI 0.94-1.42). Conclusions: This large study of esophageal adenocarcinoma confirms the clinical impression that signet ring cell variant of adenocarcinoma is associated with an advanced stage at presentation and a worse prognosis independent of stage of presentation.

Cancer ◽  
2013 ◽  
Vol 119 (17) ◽  
pp. 3156-3161 ◽  
Author(s):  
Sai Yendamuri ◽  
Miriam Huang ◽  
Usha Malhotra ◽  
Graham W. Warren ◽  
Paul N. Bogner ◽  
...  

2021 ◽  
Vol 111 (1) ◽  
pp. 214-222 ◽  
Author(s):  
Andrew Tang ◽  
Jesse Rappaport ◽  
Siva Raja ◽  
Alejandro C. Bribriesco ◽  
Monisha Sudarshan ◽  
...  

2018 ◽  
Vol 24 ◽  
pp. 8524-8532 ◽  
Author(s):  
Jun Ren ◽  
Gengming Niu ◽  
Xin Wang ◽  
Tao Song ◽  
Zhiqing Hu ◽  
...  

2016 ◽  
Vol 1 ◽  
pp. 37-37 ◽  
Author(s):  
Ethan B. Ludmir ◽  
Benjamin Robey ◽  
Evan Shelby ◽  
Sonya V. Patel-Nguyen ◽  
Ahren Rittershaus ◽  
...  

2014 ◽  
Vol 146 (5) ◽  
pp. S-1022
Author(s):  
Stephanie G. Worrell ◽  
Steven R. DeMeester ◽  
Joseph D. Dixon ◽  
Christina L. Greene ◽  
Daniel S. Oh ◽  
...  

2020 ◽  
pp. 1-4
Author(s):  
Adrian Murillo Zolezzi

Aim: This review aims to summarize current evidence on Krukenberg Tumors (KT), addressing the main prognostic determinants and its’ management. Background: Krukenberg Tumors are rare metastatic tumors of the ovary. They were initially described by Friederich Ernst Krukenberg in 1896. They arise from extra-ovarian primary signet-ring cell carcinomas, being the gastrointestinal tract the most common site of origin. The most common clinical presentation of KT is an abdominal mass or discomfort in a premenopausal 40 to the 50-year-old woman. The prognosis is extremely poor compared to primary ovarian cancer. Results: Overall survival may vary significantly according to the choice and timing of treatment. The effective treatment strategies for KT are still controversial. However, therapeutic options include surgical resection as the mainstay of treatment when possible and the application of different Chemotherapy (CT) regimens. Conclusions: Several factors negatively affect prognosis: an incomplete metastasectomy, extensive disease at diagnosis and the origin of the tumor are the main factors that most authors agree incur in a worse prognosis. KT’s optimal therapeutic strategies are still a matter of debate, raising the need for more studies to achieve consensus.


2021 ◽  
Author(s):  
Xiaohan Lin ◽  
Biyu Chen ◽  
Wei Zheng ◽  
Shugang Yang ◽  
Guangwei Zhu ◽  
...  

Abstract Background: The objective of this study was to assess the clinical efficacy of radiotherapy combined with surgery for locally advanced gastric signet-ring-cell carcinoma (GSRCC). Methods: Clinical data of patients with locally advanced GSRCC diagnosed by postoperative pathology from 2000-2016 were collected from the US Surveillance, Epidemiology and End Results (SEER) database. All the enrolled patients were divided into three groups according to treatment type: surgery alone (S; N=727), surgery with preoperative radiotherapy (RT+S; N=138), surgery with postoperative radiotherapy (S+RT; N=548). Results: The median overall survival (OS) time in S, RT+S and S+RT group was 19, 26 and 33 months, respectively; the overall survival (OS) rate was 19.5%, 26.9% and 34.0%, respectively; the median cancer-specific survival (CSS) time was 29, 31 and 43 months, respectively; and the CSS rate was 32,4%, 35.3% and 43.6%, respectively. After performing propensity score matching (PSM), it was found that the OS rate was significantly lower in S group than in RT+S or S+RT group (all P<0.05) and the CSS rate was lower in the SA group than in the S+RT group (P<0.0001) while there was no significant difference between S and RT+S groups. The OS and CSS were not significantly different between RT+S and S+RT groups. Cox multivariate analysis showed that radiotherapy was an independent prognostic factor for OS and CSS of locally advanced GSRCC.Conclusions: Compared to surgery alone, surgery combined with preoperative or postoperative radiotherapy is beneficial to the long-term survival of patients with locally advanced GSRCC.


2019 ◽  
Author(s):  
Hui Sheng ◽  
Xiaoli Wei ◽  
Minjie Mao ◽  
Jincan He ◽  
Tianqi Luo ◽  
...  

Abstract Background: Though there have been studies investigating the clinicopathologic and prognostic relevance of mucinous adenocarcinoma (MAC) and signet-ring cell carcinoma (SRCC) compared with classic adenocarcinoma (CA), little is known about the prognosis of adenocarcinoma with mixed subtypes (AM) and the differences among these four subtypes. Methods: The statistics of colorectal cancer registered in the Surveillance, Epidemiology and End Results (SEER) database were retrieved and analyzed. We also compared the clinicopathologic and prognostic relevance between CA, SRCC, MAC and AM. Results: The frequencies of these four subtypes were 69.9% (CA, n=15,812), 25.1% (MAC, n=5,689), 3.6% (SRCC, n=814) and 1.4% (AM, n=321). All of MAC, SRCC and AM were significantly related with aggressive features. Only SRCC and AM were independent poor prognostic markers for overall survival by multivariate analysis. The malignancy degree of AM was between MAC and SRCC according to the clinicopathologic associations. The prognosis of AM was significantly worse than MAC but comparable with SRCC. Conclusions: We confirmed the clinicopathologic relevance with aggressive features of MAC and SRCC, as well as the poor prognostic relevance of SRCC by analyzing a large study population. Furthermore, we identified AM as a rare but aggressive histologic subtype in colorectal cancer, which particular attention should be given in clinical practice.


Sign in / Sign up

Export Citation Format

Share Document